Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Cord blood fraction heals skin wounds as effectively as Actovegin.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Tofacitinib may help treat hair loss in children with alopecia areata.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.